Your browser doesn't support javascript.
loading
Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies.
Prem, Shruti; Remberger, Mats; Salas, Maria Queralt; Al-Shaibani, Zeyad; Lam, Wilson; Law, Arjun Datt; Kim, Dennis Dong Hwan; Michelis, Fotios V; Lipton, Jeffrey Howard; Mattsson, Jonas; Kumar, Rajat; Ellison, Cynthia; Viswabandya, Auro.
Afiliação
  • Prem S; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Remberger M; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Salas MQ; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.
  • Al-Shaibani Z; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Lam W; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Law AD; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Michelis FV; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Mattsson J; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Kumar R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Ellison C; Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Bone Marrow Transplant ; 56(3): 689-691, 2021 03.
Article em En | MEDLINE | ID: mdl-32801316
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2021 Tipo de documento: Article